6.7 C
Glasgow
Monday, March 2, 2026
spot_img

More News

Pfizer metastatic colorectal cancer treatment gets FDA approval

Jim Cornall -
Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI (encorafenib)...

Every Cure to receive up to $76m to advance AI-identified drug repurposing opportunities

Jim Cornall -
Every Cure, a nonprofit with a mission to save and improve lives by repurposing existing medicines, has been selected...

Key protein in Alzheimer’s disease protection

Jim Cornall -
Alzheimer’s disease affects approximately 50m people worldwide and is a devastating disease with limited treatment options currently available. "Alzheimer's is...

Machine-learning biomarker identifies those at high risk for liver cancer

Jim Cornall -
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a...

New AI approach enables diagnosis and monitoring of brain tumours

Jim Cornall -
An international research team, with significant involvement from the Medical University of Vienna, has developed a new AI-based analysis...

Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins

Jim Cornall -
Nuclera and leadXpro are set to collaborate by bringing together eProtein Discovery's rapid multiplex membrane protein screening with leadXpro's...

Korsana Biosciences emerges from stealth with $175m to tackle neurodegenerative diseases

Jim Cornall -
Korsana Biosciences, Inc., a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, has...

New centre for cell research

Jim Cornall -
A new centre for cell research is being set up at the University of Konstanz in Germany. The Single Cell...

PLL Therapeutics reports results from ALS trial

Jim Cornall -
PLL Therapeutics, a biopharmaceutical company developing a groundbreaking polypeptide delivery platform to treat the root cause of autoimmune and...

Aggressive oral cancer can be identified at an early stage by changes in lymphatic vessels

Jim Cornall -
Oral cancers are the most common malignant tumours in the head and neck region, causing more than 188,000 deaths...

Stopping malignant stem cells from becoming cancer cells

Jim Cornall -
In a new study in Nature Communications, a research team at the University of Oslo in Norway have examined...

Bacteria with built-in compass could be used as microbots for drug delivery

Jim Cornall -
Some bacterial species can use the Earth’s magnetic field to orient themselves. To better understand this, a team led by...

Base to Base biotech podcast 47: Accurate prostate cancer diagnosis and ocular gene therapy

Jim Cornall -
The conversations on this week’s podcast focus on a rapid and accurate prostate cancer diagnostic test, with Valley Diagnostics’...

Modifying CAR T-cells to kill solid tumours

Jim Cornall -
A team led by LMU physician Sebastian Kobold has found a way to allow the body’s immune system to...

New company created to tackle paediatric cerebral palsy

Jim Cornall -
Kidswell Bio Corporation and Treehill Partners are creating a new US-based regenerative medicine company, Kidswell USA. It is being formed...

Strategic partnership to advance space-based life sciences research infrastructure

Jim Cornall -
Azenta, Inc. has announced a strategic partnership with Frontier Space to conduct scientific experiments in space. The collaboration aims to...

HanchorBio receives FDA Orphan Drug Designation for gastric cancer drug

Jim Cornall -
HanchorBio, Inc. has announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to its...

Collaboration to develop novel therapies for neutrophil-derived inflammatory diseases

Jim Cornall -
Evogene Ltd., Systasy Bioscience GmbH, and LMU University Hospital Munich, are set to collaborate to accelerate the development of...

Kainova Therapeutics raises C$32m to develop immuno-oncology and inflammation therapies

Jim Cornall -
Kainova Therapeutics has closed a Series B financing round of C$32m. The investment supports the clinical advancement of its GPCR-targeting...

AmacaThera named Life Sciences Ontario Emerging Company of the Year

Jim Cornall -
AmacaThera, a developer of next-generation hydrogel-based drug delivery solutions, has been named Emerging Company of the Year by Life...

Syngene and Johns Hopkins University to advance early-stage drug discovery

Jim Cornall -
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced a strategic collaboration with Johns Hopkins...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media